Aduro Biotech, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies that are designed to harness the body’s natural immune system for the treatment of patients with challenging diseases. Aduro’s product candidates in the Stimulator of Interferon Genes (STING) and A Proliferation Inducing Ligand (APRIL) pathways are being investigated in cancer, autoimmune and inflammatory diseases. ADU-S100 (MIW815), which potentially activates the intracellular STING receptor for a potent tumor-specific immune response, is being evaluated in patients with cutaneously accessible metastatic solid tumors or lymphomas. BION-1301, a first-in-class humanized IgG4 monoclonal antibody that fully blocks APRIL binding to both the BCMA and TACI receptors, is being evaluated in IgA nephropathy. Aduro is collaborating with a number of leading global pharmaceutical companies to help expand and drive its product pipeline.
Location: United States, California, Berkeley
Total raised: $51.4M
Investors 2
| Date | Name | Website |
| - | Foresite C... | foresiteca... |
| - | Johns Hopk... | ventures.j... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 05.01.2015 | Series D | $51.4M | - |
Mentions in press and media 4
| Date | Title | Description | Source |
| 02.09.2016 | Triton Systems Receives $500k SBIR Grant | Triton Systems, Inc., a Chelmsford, MA-based global business venture company that launches innovativ... | finsmes.co... |
| 29.06.2016 | The biotech IPO feast flags as investors lose their appeti... | There was a time after the 2008 crash that biotech IPOs were about as popular as snow in March. B... | endpts.com... |
| 09.01.2015 | Aduro Biotech Grabs $51.4M in Series D | BERKELEY, CA, Clinical-stage immuno-oncology company, today announced the closing of a $51.4 milli... | vcnewsdail... |
| 05.01.2015 | Aduro Biotech Closes $51.4M Series D Financing | Aduro Biotech, Inc., a Berkeley, California-based clinical-stage immuno-oncology company, closed a $... | finsmes.co... |